PPH Advocacy Meeting

On July 14-15, Family Care International, working in collaboration with Gynuity Health Projects, brought together more than 50 leading advocates, health providers, program managers, and policy makers to discuss and develop advocacy strategies for improving access to misoprostol for prevention and treatment of postpartum hemorrhage (PPH). At the meeting, participants identified opportunities and challenges for promoting access to misoprostol for PPH; reviewed advocacy and policy strategies; drafted a set of core advocacy messages; and provided input on a draft advocacy communications strategy. Gynuity staff members opened the meeting with presentations on current evidence on misoprostol’s role in the prevention and treatment of PPH, and the policy framework for misoprostol for PPH.

A key output from the meeting was a set of draft advocacy messages to promote misoprostol’s role in PPH prevention and treatment with a range of audiences at the global, regional, and country levels. These messages will provide a framework for driving policy change and expanding access to misoprostol in the coming years.